SCHEMBL6404731

SCHEMBL6404731

COc1ccccc1OCc1nnc(S)n1Cc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.59
GAA P10253 1/20 0.59
NPSR1 Q6W5P4 1/20 0.59
SIRT2 Q8IXJ6 2/20 0.47
TDP1 Q9NUW8 1/20 0.47
KMT2A Q03164 5/20 0.47
MEN1 O00255 4/20 0.47
L3MBTL1 Q9Y468 1/20 0.46
PKM P14618 3/20 0.45
LMNA P02545 2/20 0.44
HPGD P15428 1/20 0.44
RAB9A P51151 1/20 0.44
HTR1A P08908 1/20 0.44
ADRA1D P25100 1/20 0.44
ADRA1A P35348 1/20 0.44
ADRA1B P35368 1/20 0.44
DRD4 P21917 1/20 0.44
KDM4E B2RXH2 1/20 0.43
THRB P10828 1/20 0.42
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6409749 0.85 MEN1 (0.59) ALDH1A1GAANPSR1TDP1KMT2A
SCHEMBL6402280 0.79 RAB9A (0.56) ALDH1A1GAANPSR1TDP1KMT2A
SCHEMBL6405892 0.78 MAPT (0.60) ALDH1A1GAANPSR1SIRT2KMT2A
SCHEMBL6406802 0.76 KMT2A (0.57) ALDH1A1GAANPSR1KMT2AL3MBTL1
SCHEMBL15801095 0.75 KDM4E (0.45) ALDH1A1NPSR1KMT2AMEN1LMNA
SCHEMBL10012854 0.74 SMN1; SMN2 (0.52) ALDH1A1NPSR1KMT2AMEN1LMNA
SCHEMBL10480359 0.74 ALDH1A1 (0.51) ALDH1A1GAANPSR1KMT2AMEN1
SCHEMBL10480370 0.73 CYP19A1 (0.45) ALDH1A1NPSR1LMNAKDM4ETSHR
SCHEMBL10011720 0.73 PDE4A (0.49) ALDH1A1GAANPSR1KMT2AMEN1
SCHEMBL5012601 0.72 SMN1; SMN2 (0.41) ALDH1A1NPSR1KMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof AGRIUS GROUP, LLC. 2005-12-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288347-A1 Certain triazole-based compounds, compositions, and uses thereof ABCG2, ATP5ME, DNTT ALDH1A1 720/4885GAA 85/4885NPSR1 4536/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.